Drug Allergy
American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma & ImmunologyPublished: February 16, 2023
- Key Points
- Tables
- List of Consensus-based Statements
- Testing Procedures for Delayed HSRs
- Contraindications to Drug Challenges
- Open Drug Challenge Protocols for Immediate Reactions
- Single-blind Placebo-controlled Challenge Protocols
- Open Drug Challenge Protocols for Non-severe Delayed Reactions
- Testing Options for Delayed HSRs
- HLA Associations With Delayed Drug HSRs
- Drugs With No or Weak Evidence of Cross-reactivity
- Groups of Beta-lactam Antibiotics that Share Side Chains
- Immediate Hypersensitivity Cephalosporin Skin Testing
- Criteria For 1- or 2-step TMP-SMX Oral Challenge and Exclusion
- Classification of Common Aspirin/NSAID HSRs
- COX-1 and COX-2 Inhibiting Medications
- Clinical Characteristics Determining the Need for Challenge versus Desensitization in AERD Patients
- Graded Aspirin Challenge Protocol for Patients With Cardiovascular Disease
- Various Commonly Utilized Aspirin Desensitization Protocols for AERD
- NSAID Classification Based on Chemical Structure
- Rapid Low Dose Aspirin Graded Challenge for Cardiovascular Emergencies
- Incidence and Characteristics of Chemotherapeutic HSRs
- Figures
- Timeline of Drug HSRs
- Recommended Approach to Beta-lactam Administration
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.